⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3959664 | 0.72 | — | — | |
| SCHEMBL3241325 | 0.65 | — | — | |
| SCHEMBL9580814 | 0.62 | — | — | |
| SCHEMBL4057990 | 0.61 | — | — | |
| SCHEMBL56970 | 0.61 | — | — | |
| SCHEMBL668215 | 0.61 | — | — | |
| SCHEMBL25386911 | 0.55 | — | — | |
| SCHEMBL912326 | 0.55 | — | — | |
| SCHEMBL911267 | 0.55 | — | — | |
| SCHEMBL911988 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12508320-B2 | Drug conjugate, pharmaceutical composition and method of treating hepatitis | SeeCure Taiwan Co., Ltd. (TW) | 2025-12-30 | — | — | US | claimed |
| US-20250283161-A1 | PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING | GRAIL, LLC | 2025-09-11 | — | — | US | claimed |
| WO-2025151707-A1 | METHOD FOR PREPARING MULTIMERS OF PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | ENTRADA THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250205257-A1 | CYCLIC CIDOFOVIR OR A PRODRUG THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF AFRICAN SWINE FEVER | VIROVET NV (BE) | 2025-06-26 | — | — | US | claimed |
| US-20250154504-A1 | GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA | PROQR THERAPEUTICS II B.V. (NL) | 2025-05-15 | — | — | US | claimed |
| EP-4518869-A1 | CYCLIC CIDOFOVIR OR A PRODRUG THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF AFRICAN SWINE FEVER | ViroVet NV (BE) | 2025-03-12 | — | — | EP | claimed |
| CN-119564873-A | Aptamer probe for targeting EpCAM and preparation method and application thereof | 四川迪亚生物科技集团有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-20250032621-A1 | DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATITIS | SeeCure Taiwan Co., Ltd. (TW) | 2025-01-30 | — | — | US | claimed |
| EP-4483906-A1 | DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATITIS | SeeCure Taiwan Co., Ltd. (TW) | 2025-01-01 | — | — | EP | claimed |
| EP-4479535-A1 | GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA | ProQR Therapeutics II B.V. (NL) | 2024-12-25 | — | — | EP | claimed |
| WO-2023214017-A1 | CYCLIC CIDOFOVIR OR A PRODRUG THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF AFRICAN SWINE FEVER | VIROVET NV (BE) | 2023-11-09 | — | — | WO | claimed |
| EP-4263862-A1 | PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING | Grail, LLC (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2023152371-A1 | GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA | PROQR THERAPEUTICS II B.V. (NL) | 2023-08-17 | — | — | WO | claimed |
| US-20230114866-A1 | VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES | SYNAFFIX B.V. (NL) | 2023-04-13 | — | — | US | claimed |
| US-20230039928-A1 | Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease | PROQR THERAPEUTICS II B.V. (NL) | 2023-02-09 | — | — | US | claimed |
| EP-4090379-A1 | VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES | Synaffix B.V. (NL) | 2022-11-23 | — | — | EP | claimed |
| EP-4081638-A1 | ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE | ProQR Therapeutics II B.V. (NL) | 2022-11-02 | — | — | EP | claimed |
| WO-2022133335-A1 | PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING | Grail, Inc. (US) | 2022-06-23 | — | — | WO | claimed |
| US-20220054645-A1 | Targeted Delivery of Therapeutic Molecules | Zhang, Peter (CN) | 2022-02-24 | — | — | US | claimed |
| WO-2016203005-A1 | TRANSITION METAL PHOSPHINO-OXAZOLINE CATALYSTS, PROCESSES FOR THEIR PRODUCTION, AND USES THEREOF IN THE HYDROGENATION OF CYCLIC ENAMIDES AND IMINES | FUNDACIÓ INSTITUT DE RECERCA BIOMÈDICA (IRB BARCELONA) (ES) | 2016-12-22 | — | — | WO | claimed |